rs398122516
Variant names:
Variant summary
Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PVS1_StrongPM2PP5
The NM_000307.5(POU3F4):c.950dupT(p.Leu317PhefsTer12) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (no stars).
Frequency
Genomes: not found (cov: 24)
Consequence
POU3F4
NM_000307.5 frameshift
NM_000307.5 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.04
Publications
9 publications found
Genes affected
POU3F4 (HGNC:9217): (POU class 3 homeobox 4) This gene encodes a member of the POU-III class of neural transcription factors. This family member plays a role in inner ear development. The protein is thought to be involved in the mediation of epigenetic signals which induce striatal neuron-precursor differentiation. Mutations in this gene are associated with X chromosome-linked nonsyndromic mixed deafness. [provided by RefSeq, Dec 2012]
POU3F4 Gene-Disease associations (from GenCC):
- nonsyndromic genetic hearing lossInheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
- X-linked mixed hearing loss with perilymphatic gusherInheritance: XL Classification: STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
- mitochondrial non-syndromic sensorineural hearing lossInheritance: Mitochondrial Classification: SUPPORTIVE Submitted by: Orphanet
- choroideremia-deafness-obesity syndromeInheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_pathogenic. The variant received 7 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. There are 19 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant X-83509272-G-GT is Pathogenic according to our data. Variant chrX-83509272-G-GT is described in ClinVar as Pathogenic. ClinVar VariationId is 41457.Status of the report is no_assertion_criteria_provided, 0 stars.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| POU3F4 | NM_000307.5 | c.950dupT | p.Leu317PhefsTer12 | frameshift_variant | Exon 1 of 1 | ENST00000644024.2 | NP_000298.3 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| POU3F4 | ENST00000644024.2 | c.950dupT | p.Leu317PhefsTer12 | frameshift_variant | Exon 1 of 1 | NM_000307.5 | ENSP00000495996.1 | |||
| ENSG00000307072 | ENST00000823276.1 | n.211dupA | non_coding_transcript_exon_variant | Exon 2 of 2 | ||||||
| ENSG00000307072 | ENST00000823277.1 | n.158dupA | non_coding_transcript_exon_variant | Exon 2 of 2 | ||||||
| ENSG00000279437 | ENST00000625081.1 | n.-59dupA | upstream_gene_variant | 6 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD3 genomes
Cov.:
24
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 24
GnomAD4 genome
Cov.:
24
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
X-linked mixed hearing loss with perilymphatic gusher Pathogenic:1
Feb 01, 2013
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.